BioNTech and its partner, Pfizer, will seek emergency approval for their Covid-19 vaccine candidate.<br />The drug companies will file paperwork for the emergency use of the vaccine with the US Food and Drug Administration (FDA).<br />In a final analysis of the Phase 3 trial, the vaccine was found to be 95% effective in preventing Covid-19.<br />The vaccine has been shown to work in all age populations.<br />According to CNN, the new vaccine has shown no serious safety concerns.<br />Drug company execs predict distribution to begin before the end of 2020.
